Effect of epigenetic modulation on cancer sphere

  • Iwahashi Shuichi
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Shimada Mitsuo
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Morine Yuji
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Imura Satoru
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Ikemoto Tetsuya
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Saito Yu
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Yamada Shinihiro
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • Utsunomiya Tohru
    Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan

この論文をさがす

抄録

<p>Background : Cancer stem cell properties are highly relevant to the biology of treatment-resistant cancers. Epigenetic modification regulates gene expressions by chromatin remodeling during malignant transformation. The aim of this study was to elucidate the possible strategy for cancer stem cells focusing on epigenetic modification. Methods : We made cancer sphere from HepG2 cells, and we added Histone deacetylase (HDAC) inhibitor, valproic acid to cancer sphere. And we compared methylation status and the gene expression between normal HepG2 and cancer sphere groups, and between cancer sphere and sphere with HDAC inhibitor treatment groups. Results : Valproic acid (VPA) cancelled this spheroid formation. In comparison between normal HepG2 and cancer sphere, the number of methylation status changes more than 0.1 of beta level was 826 probes, and we could isolate some epithelial-mesenchymal transition (EMT) related genes. And VPA reduced the expressions of EMT related genes in sphere with RT-PCR. On the other hand, in comparison between cancer sphere and sphere with VPA treatment, we detected 29 probe of methylation status change, and VPA reduced the expressions of Bcl-6 in sphere. Conclusions : HDAC inhibitor affected the methylation status of cancer stem cells. Histone-acetylation might overcome treatmet-resistant cancer through the regulation of cancer stem cell. J. Med. Invest. 67 : 70-74, February, 2020</p>

収録刊行物

参考文献 (29)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ